Particle.news
Get it on Google Play
Download on the App Store
13 ARTICLES
·
3mo ago

Ebola Surges in DR Congo as Bundibugyo Strain Outruns Response

Spread to a sixth province signals the outbreak is outpacing detection, treatment, workforce capacity, raising the risk of wider regional transmission.

Passengers who disembarked from a boat intercepted by health authorities wait to be tested following the death of a passenger suspected of having Ebola, in Kinshasa, Democratic Republic of the Congo, August 6, 2026. Authorities said the passenger had disembarked earlier in the city. REUTERS/Benoit Nyemba/File Photo
Gédéon Banga Ngbape, right, an Ebola surveillance officer, arrives at his office in Nizi, Ituri province, eastern Congo, Friday, Aug. 14, 2026. (AP Photo/Dieudonne Dirole)
Members of the Civil Protection team, which works to help mitigate the spread of the Ebola virus, wearing personal protective equipment (PPE), disinfect after handling the body of an unidentified man, who according to his family, died of Ebola, in Bunia, Ituri province, Democratic Republic of Congo, July 10, 2026. REUTERS/Gradel Muyisa Mumbere/File Photo
The outbreak is killing people three times as fast as that of 2015, which was the worst in history (Photo: Dieudonne Dirole/AP)

Overview

  • By mid‑August the outbreak has produced over 4,400 confirmed cases and more than 2,000 deaths, making it the fastest‑growing Ebola epidemic on record.
  • Health officials say transmission is occurring faster than cases can be detected and isolated, with many infections and deaths happening outside health facilities and known contact lists.
  • Response capacity is strained: treatment and transit centres in Ituri are saturated and surveillance teams are exhausted, unpaid and in some areas striking over delayed wages.
  • Insecurity, community mistrust and population movement are blocking access for contact tracing, safe burials and case follow‑up, and the virus has now been recorded in a previously unaffected province, Bas‑Uele.
  • No licensed vaccine or treatment exists for the Bundibugyo strain, though early clinical trials such as Moderna’s mRNA‑1469 study have begun abroad and results remain months away.